Akcea Therapeutics to cut about 10 pct of workforce
September 06, 2018 at 16:49 PM EDT
Akcea Therapeutics Inc said on Thursday it planned to cut its workforce by about 10 percent after the U.S. health regulator declined to approve its Waylivra drug for treating a genetic disease that causes fat accumulation in blood.